Deruxtecan Analog 2 CAS:1599440-10-4 is an innovative Deruxtecan analog designed as a drug-linker conjugate, consisting of the potent Camptothecin cytotoxic agent and a specialized linker. Camptothecin, a topoisomerase I (Topo I) inhibitor, demonstrates remarkable antineoplastic activity against colorectal, breast, lung, and ovarian cancers. Deruxtecan Analog 2 is specifically developed for the preparation of anti-FGFR2 antibody-drug conjugates (ADCs), offering a promising new approach in targeted cancer therapy.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.